To summarize the potential clinical importance of these parameters, the ACE fingerprinting approach provides a relatively noninvasive way through blood sampling to eliminate sarcoidosis from consideration in selected patients with elevated ACE levels, as well as detect the presence of sarcoidosis in patients in whom low total ACE levels (often genetically determined) may result in the appropriate diagnosis not being considered. Here, ACE is linked to sarcoidosis.